Amicus Therapeutics, Inc.;NATIONAL INSTITUTES OF HEALTH
发明人:
申请号：
EP14168748.3
公开号：
EP2787345A1
申请日:
2007.05.16
申请国别(地区):
EP
年份:
2014
代理人:
摘要：
A formulation for use in the treatment of Fabry disease, wherein the formulation comprises a carrier and 1-deoxygalactonojirimycin or a salt thereof, characterized in that the 1-deoxygalactonojirimycin or a salt thereof is administered to a Fabry disease patient in an amount of 150 mg every other day.
